Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours Β· Estimated delivery Aug 12 - Aug 17
We also detected f-Cy5-GEP44 in Y1-R, Y2-R, and GLP-1R-expressing cells in these regions (Fig
10.1530/JME-19-0083 163 TorunogluS
Rather than activating only GLP-1 receptors, it is a dual agonist that also targets GIP (glucose-dependent insulinotropic polypeptide) receptors
For instance, the FDA's approval of GLP-1 agonists for both type 2 diabetes and obesity has prompted professional organizations to update their clinical guidelines, outlining specific recommendations for their use in various patient populations
- 20-40
Cytidine-5'-diphosphocholine (Citicoline): a pilot study in patients with non-arteritic ischaemic optic neuropathy
